全文获取类型
收费全文 | 2051篇 |
免费 | 132篇 |
国内免费 | 6篇 |
出版年
2023年 | 31篇 |
2022年 | 63篇 |
2021年 | 97篇 |
2020年 | 77篇 |
2019年 | 106篇 |
2018年 | 88篇 |
2017年 | 78篇 |
2016年 | 88篇 |
2015年 | 103篇 |
2014年 | 114篇 |
2013年 | 177篇 |
2012年 | 132篇 |
2011年 | 152篇 |
2010年 | 98篇 |
2009年 | 86篇 |
2008年 | 74篇 |
2007年 | 73篇 |
2006年 | 57篇 |
2005年 | 50篇 |
2004年 | 51篇 |
2003年 | 40篇 |
2002年 | 36篇 |
2001年 | 7篇 |
2000年 | 22篇 |
1999年 | 14篇 |
1998年 | 6篇 |
1996年 | 7篇 |
1995年 | 10篇 |
1994年 | 12篇 |
1993年 | 4篇 |
1992年 | 13篇 |
1991年 | 15篇 |
1990年 | 17篇 |
1989年 | 15篇 |
1988年 | 23篇 |
1987年 | 17篇 |
1986年 | 8篇 |
1985年 | 11篇 |
1984年 | 16篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 15篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1973年 | 5篇 |
1971年 | 5篇 |
排序方式: 共有2189条查询结果,搜索用时 31 毫秒
51.
52.
53.
Pirkhezranian Zana Tanhaeian Abbas Mirzaii Mehdi Sekhavati Mohammad Hadi 《International journal of peptide research and therapeutics》2020,26(3):1503-1512
International Journal of Peptide Research and Therapeutics - Cancer remains one of the leading causes of death worldwide. Introduction of natural compounds with anticancer properties can be an... 相似文献
54.
55.
Sayed Sifat Bin Nain Zulkar Khan Md. Shakil Ahmed Abdulla Faruq Tasmin Rubaia Adhikari Utpal Kumar 《International journal of peptide research and therapeutics》2020,26(4):2089-2107
International Journal of Peptide Research and Therapeutics - Lassa virus (LASV) is responsible for a type of acute viral haemorrhagic fever referred to as Lassa fever. Lack of adequate treatment... 相似文献
56.
Robert Mason Helen C. Dearden Bella Nguyen Jennifer A. Soon Jessica Louise Smith Manreet Randhawa Andrew Mant Lydai Warburton Serigne Lo Tarek Meniawy Alexander Guminski Phillip Parente Sayed Ali Andrew Haydon Georgina V. Long Matteo S. Carlino Michael Millward Victoria G. Atkinson Alexander M. Menzies 《Pigment cell & melanoma research》2020,33(2):358-365
The combination of ipilimumab and nivolumab is a highly active systemic therapy for metastatic melanoma but can cause significant toxicity. We explore the safety and efficacy of this treatment in routine clinical practice, particularly in the setting of serine/threonine‐protein kinase B‐Raf (BRAF)‐targeted therapy. Consecutive patients with unresectable stage IIIC/IV melanoma commenced on ipilimumab and nivolumab across 10 tertiary melanoma institutions in Australia were identified retrospectively. Data collected included demographics, response and survival outcomes. A total of 152 patients were included for analysis, 39% were treatment‐naïve and 22% failed first‐line BRAF/MEK inhibitors. Treatment‐related adverse events occurred in 67% of patients, grade 3–5 in 38%. The overall objective response rate was 41%, 57% in treatment‐naïve and 21% in BRAF/MEK failure patients. Median progression‐free survival was 4.0 months (95% CI, 3.0–6.0) in the whole cohort, 11.0 months (95% CI, 6.0‐NR) in treatment‐naïve and 2.0 months (95% CI, 1.4–4.6) in BRAF/MEK failure patients. The combination of ipilimumab and nivolumab can be used safely and effectively in a real‐world population. While first‐line efficacy appears comparable to trial populations, BRAF‐mutant patients failing prior BRAF/MEK inhibitors show less response. 相似文献
57.
Cora E. Lewis John P. Bantle Alain G. Bertoni George Blackburn Frederick L. Brancati George A. Bray Lawrence J. Cheskin Jeffrey M. Curtis Caitlin Egan Mary Evans John P. Foreyt Siran Ghazarian Bethany Barone Gibbs Stephen P. Glasser Edward W. Gregg Helen P. Hazuda Louise Hesson James O. Hill Edward S. Horton Van S. Hubbard John M. Jakicic Robert W. Jeffery Karen C. Johnson Steven E. Kahn Abbas E. Kitabchi Dalane Kitzman William C. Knowler Edward Lipkin Sara Michaels Maria G. Montez David M. Nathan Ebenezer Nyenwe Jennifer Patricio Anne Peters Xavier Pi‐Sunyer Henry Pownall David M. Reboussin Donna H. Ryan Thomas A. Wadden Lynne E. Wagenknecht Holly Wyatt Rena R. Wing Susan Z. Yanovski 《Obesity (Silver Spring, Md.)》2020,28(2):247-258
58.
Yasir Iftikhar Mazhar Abbas Mustansar Mubeen Muhammad Zafar-ul-Hye Faheema Bakhtawar Sonum Bashir Ashara Sajid Muhammad Asif Shabbir 《Phyton》2021,90(4):1063-1074
Tristeza is a devastating viral disease in all the citrus growing countries throughout the world and has killed millions of citrus trees in severely affected orchards. The citrus species grafted on sour orange rootstock are affected
by this disease. Predominantly, the sweet orange, grapefruit and lime trees grafted on sour orange exhibit severe
symptoms like quick decline, vein clearing, pin holing, bark scaling and degeneration leading to variable symptoms. Symptomatic expression of Citrus tristeza virus (CTV) in different hosts has been attributed to virus isolates
which are from severe to mild. Different serological and molecular assays have been deployed to differentiate the
strains of CTV. Citrus tristeza virus is diversified towards its strains on the basis of biological, serological and
molecular characterization. Phenotypic expression is due to genetic alteration and different molecular basis have
now been adopted for strain differentiation. This review will give a brief idea about the different CTV isolates,
their characterization based on nucleic acid and serological assays. Different methods along with salient features
for strain characterization has also been reviewed. This review will also open the new aspects towards formulation
of management strategies through different detection techniques. 相似文献
59.
Journal of Ichthyology - The Suez Gulf is one of the most important water bodies north of the Red Sea that contribute significantly in fish production in Egypt. The current study represents the... 相似文献
60.
Yadav Jyoti Verma Anoop Kumar Ahmad Md. Kaleem Garg Ravindra K. Shiuli Mahdi Abbas Ali Srivastava Shrikant 《Molecular biology reports》2021,48(4):3245-3252
Molecular Biology Reports - Alzheimer's disease is a common neurodegenerative disease in the elderly population and a leading cause of dementia. Genetics and environmental risk factors were... 相似文献